Similarly, constructs have been engineered with an IDH2 R140Q mutant allele to mimic AML progression due to genetic alteration and metabolic changes ([61]; www.atcc.org for IDH2R140Q). This evidence concerns the gene IDH2 and acute myeloid leukemia.